• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于维生素K环氧化物还原酶复合体亚单位1(VKORC1)基因单倍型分析以预测华法林敏感性的新型巢式等位基因特异性多重聚合酶链反应方法。

A new nested allele-specific multiplex polymerase chain reaction method for haplotyping of VKORC1 gene to predict warfarin sensitivity.

作者信息

Chua Yung An, Abdullah Wan Zaidah, Yusof Zukurnai, Gan Siew Hua

机构信息

Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.

Department of Haematology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.

出版信息

Biomed Res Int. 2014;2014:316310. doi: 10.1155/2014/316310. Epub 2014 Mar 30.

DOI:10.1155/2014/316310
PMID:24790995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3985146/
Abstract

The vitamin K epoxide reductase complex 1 gene (VKORC1) is commonly assessed to predict warfarin sensitivity. In this study, a new nested allele-specific multiplex polymerase chain reaction (PCR) method that can simultaneously identify single nucleotide polymorphisms (SNPs) at VKORC1 381, 861, 5808, and 9041 for haplotype analysis was developed and validated. Extracted DNA was amplified in the first PCR DNA, which was optimized by investigating the effects of varying the primer concentrations, annealing temperature, magnesium chloride concentration, enzyme concentration, and the amount of DNA template. The amplification products produced from the first round of PCR were used as templates for a second PCR amplification in which both mutant and wild-type primers were added in separate PCR tubes, followed by optimization in a similar manner. The final PCR products were resolved by agarose gel electrophoresis and further analysed by using a VKORC1 genealogic tree to infer patient haplotypes. Fifty patients were identified to have H1H1, one had H1H2, one had H1H7, 31 had either H1H7 or H1H9, one had H1H9, eight had H7H7, and one had H8H9 haplotypes. This is the first method that is able to infer VKORC1 haplotypes using only conventional PCR methods.

摘要

通常会评估维生素K环氧化物还原酶复合体1基因(VKORC1)以预测华法林敏感性。在本研究中,开发并验证了一种新的巢式等位基因特异性多重聚合酶链反应(PCR)方法,该方法能够同时鉴定VKORC1基因381、861、5808和9041位点的单核苷酸多态性(SNP)以进行单倍型分析。提取的DNA在第一轮PCR中进行扩增,通过研究改变引物浓度、退火温度、氯化镁浓度、酶浓度和DNA模板量的影响对其进行优化。第一轮PCR产生的扩增产物用作第二轮PCR扩增的模板,在第二轮PCR扩增中,突变型和野生型引物分别添加到不同的PCR管中,然后以类似方式进行优化。最终的PCR产物通过琼脂糖凝胶电泳进行分离,并通过使用VKORC1系谱树进一步分析以推断患者的单倍型。鉴定出50例患者具有H1H1单倍型,1例具有H1H2单倍型,1例具有H1H7单倍型,31例具有H1H7或H1H9单倍型,1例具有H1H9单倍型,8例具有H7H7单倍型,1例具有H8H9单倍型。这是第一种仅使用常规PCR方法就能推断VKORC1单倍型的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b7/3985146/7a15b9f2f35d/BMRI2014-316310.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b7/3985146/161d99b31305/BMRI2014-316310.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b7/3985146/7a15b9f2f35d/BMRI2014-316310.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b7/3985146/161d99b31305/BMRI2014-316310.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b7/3985146/7a15b9f2f35d/BMRI2014-316310.002.jpg

相似文献

1
A new nested allele-specific multiplex polymerase chain reaction method for haplotyping of VKORC1 gene to predict warfarin sensitivity.一种用于维生素K环氧化物还原酶复合体亚单位1(VKORC1)基因单倍型分析以预测华法林敏感性的新型巢式等位基因特异性多重聚合酶链反应方法。
Biomed Res Int. 2014;2014:316310. doi: 10.1155/2014/316310. Epub 2014 Mar 30.
2
Warfarin Metabolites in Patients Following Cardiac Valve Implantation: A Contribution of Clinical and Genetic Factors.心脏瓣膜植入术后患者体内的华法林代谢产物:临床和遗传因素的作用
Cardiovasc Drugs Ther. 2015 Jun;29(3):257-64. doi: 10.1007/s10557-015-6591-8.
3
Comparative genetics of warfarin resistance.华法林耐药性的比较遗传学
Hamostaseologie. 2014;34(2):143-59. doi: 10.5482/HAMO-13-09-0047. Epub 2013 Nov 29.
4
The VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populations.德系犹太人及埃塞俄比亚人群中的维生素K环氧化物还原酶复合体亚单位1(VKORC1)Asp36Tyr变异体和VKORC1单倍型多样性
J Appl Genet. 2014 May;55(2):163-71. doi: 10.1007/s13353-013-0189-2. Epub 2014 Jan 15.
5
Mutations in CYP2C9 and/or VKORC1 haplotype are associated with higher bleeding complications in patients with Budd-Chiari syndrome on warfarin.CYP2C9 和/或 VKORC1 单倍型突变与华法林治疗的布加综合征患者出血并发症增加相关。
Hepatol Int. 2019 Mar;13(2):214-221. doi: 10.1007/s12072-018-9922-6. Epub 2019 Jan 8.
6
VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.埃及华法林抵抗患者的维生素K环氧化物还原酶复合体亚单位1(VKORC1)和细胞色素P450 2C9(CYP2C9)基因型
Blood Coagul Fibrinolysis. 2016 Mar;27(2):121-6. doi: 10.1097/MBC.0000000000000168.
7
Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients.验证一种基于埃及患者基因构成的华法林剂量算法。
Mol Diagn Ther. 2013 Dec;17(6):381-90. doi: 10.1007/s40291-013-0046-3.
8
Confirmation of warfarin resistance of naturally occurring VKORC1 variants by coexpression with coagulation factor IX and in silico protein modelling.通过与凝血因子 IX 共表达和计算机蛋白质建模证实天然存在的 VKORC1 变异体对抗华法林的耐药性。
BMC Genet. 2014 Feb 4;15:17. doi: 10.1186/1471-2156-15-17.
9
Genetic polymorphisms in warfarin and tacrolimus-related genes VKORC1, CYP2C9 and CYP3A5 in the Greek-Cypriot population.希腊塞浦路斯人群中与华法林和他克莫司相关基因VKORC1、CYP2C9和CYP3A5的基因多态性。
BMC Res Notes. 2014 Mar 5;7:123. doi: 10.1186/1756-0500-7-123.
10
Pharmacogenetics-Based Warfarin Dosing in Patients With Cardiac Valve Replacement: The Effects of CYP2C9 and VKORC1 Gene Polymorphisms.心脏瓣膜置换患者基于药物遗传学的华法林剂量:CYP2C9和VKORC1基因多态性的影响
Lab Med. 2017 Dec 22;49(1):25-34. doi: 10.1093/labmed/lmx072.

引用本文的文献

1
Non-invasive prenatal diagnosis using fetal DNA in maternal plasma: a preliminary study for identification of paternally-inherited alleles using single nucleotide polymorphisms.利用孕妇血浆中胎儿DNA进行无创产前诊断:一项使用单核苷酸多态性鉴定父系遗传等位基因的初步研究。
BMJ Open. 2015 Jul 22;5(7):e007648. doi: 10.1136/bmjopen-2015-007648.

本文引用的文献

1
Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes.采用新型即时检测 HyBeacon®探针对 CYP2C9 和 VKORC1 等位基因进行基因分型。
Clin Chim Acta. 2011 Nov 20;412(23-24):2063-9. doi: 10.1016/j.cca.2011.07.013. Epub 2011 Jul 29.
2
Clinical significance of combined CYP2C9 and VKORC1 genotypes in Japanese patients requiring warfarin.CYP2C9和VKORC1基因联合基因型在需要华法林治疗的日本患者中的临床意义
Int Heart J. 2011;52(1):44-9. doi: 10.1536/ihj.52.44.
3
Integration of genetic, clinical, and INR data to refine warfarin dosing.
整合基因、临床和 INR 数据以优化华法林剂量。
Clin Pharmacol Ther. 2010 May;87(5):572-8. doi: 10.1038/clpt.2010.13. Epub 2010 Apr 7.
4
A multiplex assay for detecting genetic variations in CYP2C9, VKORC1, and GGCX involved in warfarin metabolism.一种用于检测参与华法林代谢的CYP2C9、VKORC1和GGCX基因变异的多重检测方法。
Clin Chem. 2009 Apr;55(4):823-6. doi: 10.1373/clinchem.2008.118497. Epub 2009 Feb 20.
5
SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement.基于SYBR Green的实时PCR检测法,用于检测影响华法林剂量需求的维生素K环氧化物还原酶复合体亚单位1(VKORC1)和细胞色素P450 2C9(CYP2C9)基因多态性。
Clin Chem Lab Med. 2009;47(1):26-31. doi: 10.1515/CCLM.2009.008.
6
Gamma-glutamyl carboxylase (GGCX) tagSNPs have limited utility for predicting warfarin maintenance dose.γ-谷氨酰羧化酶(GGCX)标签单核苷酸多态性在预测华法林维持剂量方面的作用有限。
J Thromb Haemost. 2007 Nov;5(11):2227-34. doi: 10.1111/j.1538-7836.2007.02744.x. Epub 2007 Aug 22.
7
Estimation of warfarin maintenance dose based on VKORC1 (-1639 G>A) and CYP2C9 genotypes.基于维生素K环氧化物还原酶复合体亚单位1(VKORC1)(-1639 G>A)和细胞色素P450 2C9(CYP2C9)基因分型对华法林维持剂量的估算
Clin Chem. 2007 Jul;53(7):1199-205. doi: 10.1373/clinchem.2006.078139. Epub 2007 May 17.
8
Evaluation of genetic factors for warfarin dose prediction.用于华法林剂量预测的遗传因素评估。
Clin Med Res. 2007 Mar;5(1):8-16. doi: 10.3121/cmr.2007.724.
9
1173C>T polymorphism in VKORC1 modulates the required warfarin dose.维生素K环氧化物还原酶复合体亚单位1(VKORC1)基因1173C>T多态性可调节华法林所需剂量。
Pediatr Cardiol. 2006 Nov-Dec;27(6):685-8. doi: 10.1007/s00246-005-1150-x.
10
A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.一种针对亚洲人的华法林剂量模型,该模型利用维生素K环氧化物还原酶复合物和细胞色素P450 2C9中的单核苷酸多态性。
Clin Pharmacol Ther. 2006 Oct;80(4):346-55. doi: 10.1016/j.clpt.2006.06.009.